Location, location, location-gene expression studies of brainstem ganglioglioma: A rare tumor in a very rare location

Pediatric Blood and Cancer

Volumn 59, Issue 7, 2012, Pages 1153-1154

  Wetmore, Cynthia ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; ISOCITRATE DEHYDROGENASE 1; NOCICEPTIN; OPIATE RECEPTOR; PREPRONOCICEPTIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMYGDALOID NUCLEUS; BRAIN STEM; BRAIN STEM TUMOR; CANCER GROWTH; CLINICAL FEATURE; CYTOPLASM; EVENT FREE SURVIVAL; FOCAL EPILEPSY; FRONTAL LOBE; GENE EXPRESSION; GLIOMA; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LIGAND BINDING; LOCUS CERULEUS; MALIGNANT TRANSFORMATION; NEUROBLASTOMA; NEUROEPITHELIUM; NONHUMAN; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SOMATIC MUTATION; TUMOR LOCALIZATION; TUMOR MICROENVIRONMENT;

BRAIN STEM NEOPLASMS; FEMALE; GANGLIOGLIOMA; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROTEIN PRECURSORS; RECEPTORS, OPIOID;

EID: 84867378342     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24287     Document Type: Note

References (22)

1. Smith MA, Freidlin B, Ries LA, et al. Trends in reported incidence of primary malignant brain tumors in children in the United States. J Natl Cancer Inst 1998; 90: 1269-1277.
2. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: Critical review of clinical trials. Lancet Oncol 2006; 7: 241-248.
3. Donaldson SS, Laningham F, Fisher PG. Advances toward an understanding of brainstem gliomas. J Clin Oncol 2006; 24: 1266-1272.
4. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
5. Nelson JS. Gangliogliomas and gangliocytomas. Lyon: International Agency for Research in Cancer Press; 2000.
6. Luyken C, Blumcke I, Fimmers R, et al. Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 2004; 101: 146-155.
7. Schramm J, Kral T, Grunwald T, et al. Surgical treatment for neocortical temporal lobe epilepsy: Clinical and surgical aspects and seizure outcome. J Neurosurg 2001; 94: 33-42.
8. El Khashab M, Gargan L, Margraf L, et al. Predictors of tumor progression among children with gangliogliomas. Clinical article. J Neurosurg Pediatr 2009; 3: 461-466.
9. Lee CC, Wang WH, Lin CF, et al. Malignant transformation of supratentorial ganglioglioma. Clin Neurol Neurosurg 2012 [Epub 2 April 2012].
10. Lagares A, Gomez PA, Lobato RD, et al. Ganglioglioma of the brainstem: Report of three cases and review of the literature. Surg Neurol 2001; 56: 315-322; discussion 322-314.
11. Lang FF, Epstein FJ, Ransohoff J, et al. Central nervous system gangliogliomas. Part 2: Clinical outcome. J Neurosurg 1993; 79: 867-873.
12. Mollereau C, Parmentier M, Mailleux P, et al. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 1994; 341: 33-38.
13. Neal CR, Jr., Akil H, Watson SJ, Jr. Expression of orphanin FQ and the opioid receptor-like (ORL1) receptor in the developing human and rat brain. J Chem Neuroanat 2001; 22: 219-249.
14. Reinscheid RK, Civelli O. The orphanin FQ/nociceptin knockout mouse: A behavioral model for stress responses. Neuropeptides 2002; 36: 72-76.
15. Mogil JS, Grisel JE, Reinscheid RK, et al. Orphanin FQ is a functional anti-opioid peptide. Neuroscience 1996; 75: 333-337.
16. Saito Y, Maruyama K, Saido TC, et al. Overexpression of a neuropeptide nociceptin/orphanin FQ precursor gene, N23K/N27K, induces neurite outgrowth in mouse NS20Y cells. J Neurosci Res 1997; 48: 397-406.
17. Zaveri NT, Waleh N, Toll L. Regulation of the prepronociceptin gene and its effect on neuronal differentiation. Gene 2006; 384: 27-36.
18. Horbinski C, Kofler J, Yeaney G, et al. Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas. Brain Pathol 2011; 21: 564-574.
19. Sanson M, Marie Y, Paris S, et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 2009; 27: 4150-4154.
20. Dougherty MJ, Santi M, Brose MS, et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 2010; 12: 621-630.
21. Schindler G, Capper D, Meyer J, et al. Analysis of BRAF V600E mutation in 1, 320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 2011; 121: 397-405.
22. Blumcke I, Wiestler OD. Gangliogliomas: An intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 2002; 61: 575-584.